Prescribing of diabetes medications to people with type 2 diabetes and chronic kidney disease: a national cross-sectional study
Jo-Anne Manski-Nankervis, Sharmala Thuraisingam, Janet K Sluggett, Gary Kilov, John Furler, David O'Neal, Alicia Jenkins
BMC FAMILY PRACTICE | BMC | Published : 2019
BACKGROUND: Previous studies in general practice and hospital settings have identified that prescribing of non-insulin diabetes medications may be sub-optimal in people with type 2 diabetes (T2D) and renal impairment. Since these publications, a number of new medications have become available for the management of T2D. Study aims were to, in a cohort of Australians with T2D and renal impairment attending general practice, (1) investigate whether the prescribing of non-insulin diabetes medications is consistent with dosing adjustments recommended within current Australian Diabetes Society (ADS) guidelines; and (2) identify patient socio-demographic and clinical factors associated with at leas..View full abstract
This study was funded by Boehringer Ingelheim and Eli Lilly and commissioned by VentureWise (a wholly owned commercial subsidiary of NPS MedicineWise). Boehringer Ingelheim and Eli Lilly had no role in study design and conduct; in the collection, analysis and interpretation of the data; or in the preparation or approval of the manuscript.